Name
Marja Apteek OÜ
Registry code
11458305
VAT number
EE101286493
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
10.01.2008 (16)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
47731 - Dispensing chemist in specialised stores
6 104 076 €
34 954 €
1%
2 693 €
(estimate is approximate)
225 672 €
17
Submitted
No tax arrears
15%
2%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Andre Vetka 25.02.1980 (44) | 50% - 1 279.00 EUR | Board member | Direct ownership | Founder |
| OÜ Inspira Invest 12055354 | 50% - 1 277.00 EUR | - | - |
| 2019 05.06.2020 | 2020 30.06.2021 | 2021 08.06.2022 | 2022 30.06.2023 | 2023 07.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 5 684 315 € | 5 836 324 € | 5 695 062 € | 5 911 866 € | 6 104 076 € |
| Net profit (loss) for the period | 116 027 € | 60 994 € | 96 918 € | 22 299 € | 34 954 € |
| Profit Margin | 2% | 1% | 2% | 0% | 1% |
| Current Assets | 1 263 473 € | 1 379 126 € | 1 077 380 € | 1 143 570 € | 1 211 822 € |
| Fixed Assets | 187 845 € | 223 681 € | 454 609 € | 392 484 € | 329 805 € |
| Total Assets | 1 451 318 € | 1 602 807 € | 1 531 989 € | 1 536 054 € | 1 541 627 € |
| Current Liabilities | 1 200 573 € | 1 383 090 € | 1 204 930 € | 1 284 540 € | 1 315 955 € |
| Non Current Liabilities | 16 746 € | 0 € | 71 500 € | 0 € | - |
| Total Liabilities | 1 217 319 € | - | 1 276 430 € | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 233 999 € | 219 717 € | 255 559 € | 251 514 € | 225 672 € |
| Employees | 19 | 20 | 19 | 18 | 17 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 1 651 960.94 € | 107 792.49 € | 77 069.3 € | 18 |
| 2023 Q4 | 1 600 138.53 € | 93 301.08 € | 71 353.43 € | 18 |
| 2023 Q3 | 1 465 024.43 € | 99 630.48 € | 71 494.1 € | 19 |
| 2023 Q2 | 1 461 372.77 € | 86 218.04 € | 71 250.52 € | 18 |
| 2023 Q1 | 1 548 348.35 € | 106 811.21 € | 77 840.19 € | 18 |
| 2022 Q4 | 1 610 214.35 € | 102 884.37 € | 74 587.5 € | 19 |
| 2022 Q3 | 1 354 754.85 € | 87 638.17 € | 69 411.58 € | 20 |
| 2022 Q2 | 1 404 404.66 € | 79 820.44 € | 66 307.97 € | 20 |
| 2022 Q1 | 1 491 858.43 € | 105 958.82 € | 72 818.44 € | 20 |
| 2021 Q4 | 1 545 970.3 € | 84 946.84 € | 69 697.23 € | 21 |
| 2021 Q3 | 1 320 496.54 € | 78 527.3 € | 65 038.63 € | 20 |
| 2021 Q2 | 1 336 480.5 € | 67 453.67 € | 66 926.48 € | 20 |
| 2021 Q1 | 1 443 862.82 € | 80 940.36 € | 70 463.73 € | 22 |
| 2020 Q4 | 1 558 782.72 € | 73 707.15 € | 64 743.79 € | 22 |
| 2020 Q3 | 1 323 469.17 € | 87 530.36 € | 62 629.61 € | 20 |
| 2020 Q2 | 1 471 120.16 € | 91 742.7 € | 67 454.04 € | 21 |
| 2020 Q1 | 1 599 583.2 € | 100 047.12 € | 67 026.16 € | 21 |
